Primary glioblastomas express mesenchymal stem-like properties
- PMID: 16966431
- DOI: 10.1158/1541-7786.MCR-06-0005
Primary glioblastomas express mesenchymal stem-like properties
Abstract
Glioblastoma is the most common and aggressive primary brain cancer. Recent isolation and characterization of brain tumor-initiating cells supports the concept that transformed neural stem cells may seed glioblastoma. We previously identified a wide array of mesenchymal tissue transcripts overexpressed in a broad set of primary glioblastoma (de novo) tumors but not in secondary glioblastoma (derived from lower-grade) tumors, low-grade astrocytomas, or normal brain tissues. Here, we extend this observation and show that a subset of primary glioblastoma tumors and their derived tumor lines express cellular and molecular markers that are associated with mesenchymal stem cells (MSC) and that glioblastoma cell cultures can be induced to differentiate into multiple mesenchymal lineage-like cell types. These findings suggest either that a subset of primary glioblastomas derive from transformed stem cells containing MSC-like properties and retain partial phenotypic aspects of a MSC nature in tumors or that glioblastomas activate a series of genes that result in mesenchymal properties of the cancer cells to effect sustained tumor growth and malignant progression.
Similar articles
-
Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1.Cancer Lett. 2010 May 28;291(2):150-7. doi: 10.1016/j.canlet.2009.10.010. Epub 2009 Nov 13. Cancer Lett. 2010. PMID: 19913993
-
Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival.Clin Cancer Res. 2009 Nov 1;15(21):6541-50. doi: 10.1158/1078-0432.CCR-09-0695. Epub 2009 Oct 27. Clin Cancer Res. 2009. PMID: 19861460
-
Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.Am J Surg Pathol. 2007 May;31(5):760-9. doi: 10.1097/01.pas.0000213433.14740.5d. Am J Surg Pathol. 2007. PMID: 17460461
-
Glioblastoma stem cells.Cell Tissue Res. 2011 Mar;343(3):459-65. doi: 10.1007/s00441-010-1123-0. Epub 2011 Jan 21. Cell Tissue Res. 2011. PMID: 21253762 Review.
-
[Glial tumors of the brain: current aspects of the immunopathogenesis and immunogenodiagnosis].Arkh Patol. 2007 Mar-Apr;69(2):53-7. Arkh Patol. 2007. PMID: 17642197 Review. Russian.
Cited by
-
Reduced expression of the hyaluronan and proteoglycan link proteins in malignant gliomas.J Biol Chem. 2009 Sep 25;284(39):26547-56. doi: 10.1074/jbc.M109.013185. Epub 2009 Jul 24. J Biol Chem. 2009. PMID: 19633295 Free PMC article.
-
Gene regulatory networks in embryonic stem cells and brain development.Birth Defects Res C Embryo Today. 2009 Jun;87(2):182-91. doi: 10.1002/bdrc.20149. Birth Defects Res C Embryo Today. 2009. PMID: 19530135 Free PMC article. Review.
-
The transcriptional network for mesenchymal transformation of brain tumours.Nature. 2010 Jan 21;463(7279):318-25. doi: 10.1038/nature08712. Epub 2009 Dec 23. Nature. 2010. PMID: 20032975 Free PMC article.
-
Cofilin Acts as a Booster for Progression of Malignant Tumors Represented by Glioma.Cancer Manag Res. 2022 Nov 24;14:3245-3269. doi: 10.2147/CMAR.S389825. eCollection 2022. Cancer Manag Res. 2022. PMID: 36452435 Free PMC article. Review.
-
Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival.Genome Med. 2012 Oct 9;4(10):76. doi: 10.1186/gm377. eCollection 2012. Genome Med. 2012. PMID: 23046790 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials